Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1555539rdf:typepubmed:Citationlld:pubmed
pubmed-article:1555539lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:1555539lifeskim:mentionsumls-concept:C0019944lld:lifeskim
pubmed-article:1555539lifeskim:mentionsumls-concept:C0013090lld:lifeskim
pubmed-article:1555539lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1555539lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:1555539lifeskim:mentionsumls-concept:C0013125lld:lifeskim
pubmed-article:1555539pubmed:issue1lld:pubmed
pubmed-article:1555539pubmed:dateCreated1992-5-4lld:pubmed
pubmed-article:1555539pubmed:abstractTextIntravenous use of doxycycline in horses is associated with deleterious side effects on the cardiovascular system which may result in fatalities. At dosages and infusion rates used in these studies, supraventricular tachycardia, systemic arterial hypertension, clinical signs of discomfort, collapse and death were observed. Results of the present study suggest that the intravenous use of doxycycline should be avoided in horses.lld:pubmed
pubmed-article:1555539pubmed:languageenglld:pubmed
pubmed-article:1555539pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1555539pubmed:citationSubsetIMlld:pubmed
pubmed-article:1555539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1555539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1555539pubmed:statusMEDLINElld:pubmed
pubmed-article:1555539pubmed:monthJanlld:pubmed
pubmed-article:1555539pubmed:issn0425-1644lld:pubmed
pubmed-article:1555539pubmed:authorpubmed-author:RikihisaYYlld:pubmed
pubmed-article:1555539pubmed:authorpubmed-author:AtkinsC ECElld:pubmed
pubmed-article:1555539pubmed:authorpubmed-author:RiviereJ EJElld:pubmed
pubmed-article:1555539pubmed:authorpubmed-author:RiondJ LJLlld:pubmed
pubmed-article:1555539pubmed:authorpubmed-author:DuckettW MWMlld:pubmed
pubmed-article:1555539pubmed:authorpubmed-author:SpurlockS LSLlld:pubmed
pubmed-article:1555539pubmed:authorpubmed-author:JerniganA DADlld:pubmed
pubmed-article:1555539pubmed:issnTypePrintlld:pubmed
pubmed-article:1555539pubmed:volume24lld:pubmed
pubmed-article:1555539pubmed:ownerNLMlld:pubmed
pubmed-article:1555539pubmed:authorsCompleteYlld:pubmed
pubmed-article:1555539pubmed:pagination41-5lld:pubmed
pubmed-article:1555539pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:meshHeadingpubmed-meshheading:1555539-...lld:pubmed
pubmed-article:1555539pubmed:year1992lld:pubmed
pubmed-article:1555539pubmed:articleTitleCardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses and ponies.lld:pubmed
pubmed-article:1555539pubmed:affiliationDepartment of Anatomy, College of Veterinary Medicine, North Carolina State University, Raleigh 27606.lld:pubmed
pubmed-article:1555539pubmed:publicationTypeJournal Articlelld:pubmed